These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12239929

  • 1. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment.
    Guslandi M, Fanti L, Testoni PA.
    Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929
    [Abstract] [Full Text] [Related]

  • 2. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role.
    Prónai L, Schandl L, Orosz Z, Magyar P, Tulassay Z.
    Helicobacter; 2004 Jun; 9(3):278-83. PubMed ID: 15165265
    [Abstract] [Full Text] [Related]

  • 3. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease.
    Oliveira AG, Rocha GA, Rocha AM, Sanna Md, Moura SB, Dani R, Marinho FP, Moreira LS, Ferrari Mde L, Castro LP, Queiroz DM.
    Helicobacter; 2006 Feb; 11(1):2-9. PubMed ID: 16423084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease.
    Furusu H, Murase K, Nishida Y, Isomoto H, Takeshima F, Mizuta Y, Hewlett BR, Riddell RH, Kohno S.
    Hepatogastroenterology; 2002 Feb; 49(45):639-43. PubMed ID: 12063959
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
    Pearce CB, Duncan HD, Timmis L, Green JR.
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
    [Abstract] [Full Text] [Related]

  • 7. [Helicobacter pylori and nonspecific intestinal inflammation].
    Münzová H, Dítĕ P, Sevcíková I, Dolina J, Novotný I, Kunovská M.
    Vnitr Lek; 2000 Dec; 46(12):839-42. PubMed ID: 11214362
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
    Gessner BD, Bruce MG, Parkinson AJ, Gold BD, Muth PT, Dunaway E, Baggett HC.
    Clin Infect Dis; 2005 Nov 01; 41(9):1261-8. PubMed ID: 16206100
    [Abstract] [Full Text] [Related]

  • 9. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C, Berto E, Scribano ML, Falasco G.
    Ital J Gastroenterol Hepatol; 1998 Dec 01; 30(6):602-6. PubMed ID: 10076781
    [Abstract] [Full Text] [Related]

  • 10. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D.
    Int J Cardiol; 2007 Oct 18; 121(3):229-38. PubMed ID: 17368586
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and treatment of Helicobacter pylori in patients with blepharitis.
    Saccà SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, Bilardi C, Savarino V, Brusati C, Rebora A.
    Invest Ophthalmol Vis Sci; 2006 Feb 18; 47(2):501-8. PubMed ID: 16431942
    [Abstract] [Full Text] [Related]

  • 12. Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis.
    Torrente F, Anthony A, Heuschkel RB, Thomson MA, Ashwood P, Murch SH.
    Am J Gastroenterol; 2004 Apr 18; 99(4):598-605. PubMed ID: 15089888
    [Abstract] [Full Text] [Related]

  • 13. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.
    Wagtmans MJ, Witte AM, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, Lamers CB, van Hogezand RA.
    Scand J Gastroenterol; 1997 Jul 18; 32(7):712-8. PubMed ID: 9246713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.
    Vorobjova T, Nilsson I, Terjajev S, Granholm M, Lyyra M, Porkka T, Prükk T, Salupere R, Maaroos HI, Wadström T, Uibo R.
    Dig Liver Dis; 2006 Mar 18; 38(3):171-6. PubMed ID: 16464652
    [Abstract] [Full Text] [Related]

  • 16. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM.
    Hepatogastroenterology; 2004 Mar 18; 51(55):303-8. PubMed ID: 15011890
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori infection in South Nigerians: a serological study of dyspeptic patients and healthy individuals.
    Oluwasola AO, Ola SO, Saliu L, Solanke TF.
    West Afr J Med; 2002 Mar 18; 21(2):138-41. PubMed ID: 12403037
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of Helicobacter pylori infection in dyspeptic patients.
    Marusić M, Presecki V, Katicić M, Bilić A, Jurcić D, Schwarz D.
    Coll Antropol; 2008 Dec 18; 32(4):1149-53. PubMed ID: 19149222
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
    Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, Imatani A, Kato K, Shimosegawa T.
    Am J Gastroenterol; 2004 Jul 18; 99(7):1213-21. PubMed ID: 15233656
    [Abstract] [Full Text] [Related]

  • 20. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
    Atalay C, Atalay G, Altinok M.
    Neoplasma; 2003 Jul 18; 50(3):185-90. PubMed ID: 12937851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.